Blog Archives - Page 72 of 76 - NFCR

Blog

2017: The Year of Cancer Genomics

National Foundation for Cancer Research CEO Franklin Salisbury Jr. predicts: "It looks like 21st century medicine will be about cancer genomics."...

Read more

7 Cancer-Fighting New Year’s Resolutions

In honor of 2017, we’ve put together seven cancer-fighting new year's resolutions. From screenings to sunscreen, these easy resolutions are worth keeping!...

Read more

New Treatment for Glioblastoma Multiforme Developed by NFCR Scientists

Dr. Web Cavenee and Dr. Paul B. Fisher discover a new pharmacological agent to treat glioblastoma multiforme (GBM), the deadliest brain cancer....

Read more

Party4Life 2016 & the Lucy Fund

Ongoing fundraising efforts in honor of Lucy Stanovick seek to find a cure for metastatic cancer. To date, over $200,000 has been raised in Lucy’s name....

Read more

Sarah’s Story: Dr. Civin’s Cancer Research “Saved My Life”

Sarah Byrd says she owes her life to Dr. Curt Civin, a pediatric oncologist specializing in leukemia research whose work is funded by NFCR....

Read more

Genomic Testing Finds Link Between Breast and Bladder Cancer

Researchers from UNC, Chapel Hill found a subtype of bladder cancer has the same molecular signatures as a subset of breast cancer....

Read more

On the Move With Dr. Ba: 2016 Recap

NFCR President and COO, Dr. Sujuan Ba, has spent this past year traveling the world to lead efforts and collaborate with top scientists. Read about some of the conferences, people and successes in 2016....

Read more

NFCR’s Dr. Web Cavenee Honored at Prestigious Gray Gala

NBTS held its annual Gray Gala and pioneers in brain tumor research were honored, including Dr. Web Cavanee, Chairman of NFCR’s Scientific Advisory Board....

Read more

NFCR-Funded Scientist Selected as ‘Giant of Cancer Care’

Dr. Daniel Von Hoff, Director of the NFCR Center for Targeted Cancer Therapies at TGen, has been selected as a 2016 Giants of Cancer Care® by OncLive....

Read more

NFCR’s Genomics Newsroom: New Method to Detect Biomarkers

A method called MishCTC is being developed that will detect a molecular biomarker that is inside tumor cells but can’t be detected in normal blood cells....

Read more